Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

A new classification and scoring system is needed for alopecia areata to better assess severity.

Alopecia Areata is linked to higher depression levels.

People with alopecia areata had lower vitamin D levels, but these levels did not relate to how severe their condition was.

Yellow dots are common in severe alopecia areata.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Topical corticosteroids are recommended first for treating pediatric alopecia areata due to safety and ease of use.

Ritlecitinib effectively regrows eyebrow and eyelash hair in alopecia areata, with 50 mg being the best dose.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Alopecia areata significantly affects mental health, especially in women and those with severe cases.

The SAAD-41 scale effectively measures the psychosocial impact of alopecia areata.

Children with alopecia areata and their caregivers experience significant emotional and quality of life challenges.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Using a higher concentration of triamcinolone acetonide leads to faster hair regrowth in scalp patchy alopecia areata.

Vitamin D deficiency is common in children with and without alopecia areata, and more research is needed.

A new model uses specific blood markers to predict if children's hair loss will return.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Trichoscopy helps diagnose hair and scalp problems but isn't always definitive and should be used with other methods.

CD117 and platelet-derived growth factor receptor α may play a role in alopecia areata.

Baricitinib is effective and safe for treating alopecia areata in Korea.

Improved diagnosis and affordable topical treatments are essential for managing alopecia areata in India.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Low vitamin D levels are linked to severe and active alopecia areata.

Trichoscopy is good for diagnosing and monitoring hair and scalp problems in children but needs more research for certain conditions.